>중동 및 아프리카 내시경 역행성 담관췌관조영술 장치 시장, 제품 유형(내시경 치료 장치, 내시경, 영상 장치 등), 방식(단일 사용, 독립형, 핸드헬드), 시술(담관 절제술, 담관 스텐트 삽입, 담관 확장술, 췌장관 스텐트 삽입, 췌장 괄약근 절제술), 적용 분야(담관, 췌장, 담낭, 간 등), 최종 사용자(병원, 외래 수술 센터, 진단 실험실 등), 시설 유형(대형, 중형, 소형), 유통 채널(직접 입찰, 제3자 유통 및 소매 판매), 국가(남아프리카, 사우디 아라비아, UAE, 이집트, 쿠웨이트, 이스라엘 및 중동 및 아프리카의 나머지 지역) 산업 동향 및 예측 2028.
시장 분석 및 통찰력: 중동 및 아프리카 내시경 역행성 담관췌관조영술 장치 시장
중동 및 아프리카 내시경 역행성 담관췌관조영술 장치 시장은 2021년부터 2028년까지의 예측 기간 동안 성장할 것으로 예상됩니다. Data Bridge Market Research는 시장이 2021년부터 2028년까지의 예측 기간 동안 4.0%의 CAGR로 성장하고 있으며 2020년의 7,844만 달러에서 2028년까지 1억 328만 달러에 도달할 것으로 예상한다고 분석합니다. 췌장 및 담관 질환의 높은 유병률은 예측 기간 동안 시장 수요를 촉진하는 주요 동인이 될 가능성이 높습니다.
만성 질환, 췌장 종양의 높은 유병률, 의료 인프라에 대한 정부 지출 증가, 유리한 환불 시나리오가 시장 성장을 주도하고 있습니다. 그러나 장치 승인에 대한 엄격한 정부 규칙은 시장 성장을 제한하고 있습니다. 질병의 조기 진단 및 치료에 대한 사람들의 인식이 높아지면서 시장에 기회가 되고 있습니다. ERCP 시술과 관련된 부작용은 시장에 도전이 되고 있습니다.
중동 및 아프리카 내시경 역행성 담관췌관조영술 장치 시장 보고서는 시장 점유율, 새로운 개발 및 국내 및 지역 시장 참여자의 영향에 대한 세부 정보를 제공하고, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서 기회를 분석합니다. 분석 및 시장 시나리오를 이해하려면 분석가 브리핑을 위해 당사에 문의하세요. 당사 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드립니다.
중동 및 아프리카 내시경 역행성 담관췌관조영술 장비 시장 범위 및 시장 규모
The Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is categorized into seven notable segments based on product type, modality, procedure, application, end user, facility type, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product type, the Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is segmented into endotherapy devices, endoscopes, imaging devices, and others. In 2021, the endotherapy devices segment is expected to dominate the market due to the availability of various types of equipment. Big players are manufacturing this equipment in the Middle East and Africa market.
- On the basis of modality, the Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is segmented into single-use, standalone, and handheld. In 2021, the single-use segment is expected to dominate the market because there is no risk of disease transmission from one patient to another while using single-use devices.
- On the basis of procedure, the Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is segmented into biliary sphincterotomy, biliary stenting, biliary dilation, pancreatic duct stenting, and pancreatic sphincterotomy. In 2021, the biliary sphincterotomy segment is expected to dominate the market because of the high prevalence of pancreatic tumors in the Middle East and Africa region.
- On the basis of application, the Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is segmented into the bile duct, pancreas, gall bladder, liver, and others. In 2021, the bile duct segment is expected to dominate the market because of the high prevalence of biliary diseases in the Middle East and Africa region.
- On the basis of end user, the Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is segmented into hospitals, ambulatory surgical centers, diagnostic laboratories, and others. In 2021, the hospital's segment is expected to dominate the market due to the growing emphasis on strategic initiatives (such as acquisitions, partnerships, and collaborations) by medical device companies to expand their capabilities in the ERCP market.
- On the basis of facility type, the Middle East and Africa endoscopic retrograde cholangiopancreatography devices market is segmented into large, medium, and small. In 2021, the large segment is expected to dominate the market due to the high demand for ERCP procedures in the Middle East and Africa.
- 유통 채널을 기준으로 중동 및 아프리카 내시경 역행성 담관췌관조영술 장치 시장은 직접 입찰, 제3자 유통 및 소매 판매로 세분화됩니다. 2021년에는 직접 입찰 부문이 판매 및 수익 프로세스에 대한 전반적인 통제와 고객과의 직접적인 상호 작용으로 인해 상당한 성장을 이룰 것으로 예상됩니다.
중동 및 아프리카 내시경 역행성 담관췌관조영술 장비 시장 국가 수준 분석
중동 및 아프리카 내시경 역행성 담관췌관조영술 장치 시장을 분석하고, 제품 유형, 방식, 시술, 응용 분야, 최종 사용자, 시설 유형 및 유통 채널별로 시장 규모 정보를 제공합니다.
중동 및 아프리카 내시경 역행성 담관췌관조영술 장치 시장 보고서에서 다루는 국가는 남아프리카공화국, 사우디아라비아, UAE, 이집트, 쿠웨이트, 이스라엘, 그리고 나머지 중동 및 아프리카 국가입니다.
중동과 아프리카는 중동과 아프리카 국가와 마찬가지로 예측 기간 동안 4.0%의 CAGR로 성장할 것으로 예상됩니다. 담관 질환의 높은 유병률과 정부 지원. 남아프리카는 중동과 아프리카 시장에서 시장을 지배할 것으로 예상됩니다. 남아프리카는 내시경 역행성 담관췌관조영술 장치 시장을 심어주는 선도 국가 중 하나입니다.
보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 추세에 영향을 미치는 규제 변화를 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 규제 조치 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 중동 및 아프리카 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 판매 채널의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.
첨단 기술의 존재와 플레이어들이 취한 전략적 이니셔티브는 중동 및 아프리카 내시경 역행성 담관췌관조영술 장치 시장 에서 새로운 기회를 창출하고 있습니다.
중동 및 아프리카 내시경 역행성 담관췌관조영술 장치 시장은 또한 ERCP 제품 판매를 통해 특정 산업에서 모든 국가의 성장, 시장 발전의 영향, 시장을 지원하는 규제 시나리오의 변화에 대한 자세한 시장 분석을 제공합니다. 2010년부터 2019년까지의 과거 기간에 대한 데이터를 사용할 수 있습니다.
중동 및 아프리카 내시경 역행성 담관췌관조영술 장비 시장 점유율 분석 의 경쟁 환경
중동 및 아프리카 내시경 역행성 담관췌관조영술 장치 시장 경쟁 구도는 경쟁업체의 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 시험 파이프라인, 제품 승인, 특허, 제품 폭 및 범위, 응용 분야 우세, 기술 수명선 곡선이 있습니다. 위의 데이터 포인트는 내시경 역행성 담관췌관조영술 장치 시장에 대한 회사의 초점과만 관련이 있습니다.
중동 및 아프리카 지역에서 내시경 역행성 담관췌관조영술 장비를 공급하는 주요 기업으로는 Olympus Corporation, Boston Scientific Corporation, Medtronic, BD, Ambu Inc., CONMED Corporation, FUJIFILM Corporation, TeleMed Systems, Inc., Merit Medical Systems, Cook, KARL STORZ SE & Co. KG, Johnson & Johnson Services, Inc., HOYA Corporation, STERIS, Shaili Endoscopy, Hospiline Equipments 등이 있습니다.
DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.
시장 참여자들의 전략적 이니셔티브와 내시경 역행성 담관췌관조영술 장치에 대한 새로운 기술적 발전은 다양한 치료법에 대한 격차를 메우고 있습니다.
예를 들어,
- 2017년 12월, BD는 CR Bard, Inc. 인수를 완료했습니다. 이를 통해 BD의 사업이 강화되고 성장 궤적이 가속화되었으며, 특히 장기적으로 아프리카에서의 리더십이 강화될 것으로 예상됩니다.
- 2020년 12월, Johnson & Johnson Services, Inc.는 제39회 JP Morgan Healthcare Conference에 참여했다고 발표했습니다. 이를 통해 회사는 제품에 대한 올바른 지식을 제공하고 향후 몇 년 동안 회사가 더욱 성장하는 데 도움이 될 것입니다.
시장 참여자들의 협력, 합작투자 및 기타 전략은 내시경 역행성 담관췌관조영술 장비 시장에서 회사 시장을 확대하고 있으며, 이를 통해 조직이 시장에 제공하는 제품을 개선하는 데에도 도움이 됩니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEAR CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: REGIONAL SUMMARY
5.1 NORTH AMERICA
5.2 EUROPE
5.3 ASIA-PACIFIC
5.4 SOUTH AMERICA
5.5 MIDDLE EAST AND AFRICA
6 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: REGULATIONS
6.1 UNITED STATES
6.2 EUROPE
6.3 CHINA
6.4 AUSTRALIA
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 SURGE IN PREVALENCE OF PANCREATIC AND LIVER DISORDERS
7.1.2 INCREASE IN THE GERIATRIC POPULATION
7.1.3 RISING HEALTHCARE EXPENDITURE
7.1.4 HIGH PREVALENCE OF PANCREATIC CANCER
7.2 RESTRAINTS
7.2.1 HIGH COST OF DEVICES
7.2.2 STRINGENT GOVERNMENT RULES
7.2.3 EMERGENCE OF COVID-19
7.3 OPPORTUNITIES
7.3.1 STRATEGIC INITIATIVES TAKEN BY PLAYERS
7.3.2 RISE IN ALCOHOL CONSUMPTION AND SURGE IN SMOKING
7.3.3 RISING DISPOSABLE INCOME
7.3.4 GROWING MEDICAL TOURISM
7.4 CHALLENGES
7.4.1 COMPLICATIONS ASSOCIATED WITH PROCEDURE
7.4.2 SHORTAGE OF SKILLED PERSONNEL
8 IMPACT OF COVID-19 ON MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET
8.1 IMPACT ON PRICE
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY
8.4 KEY INITIATIVES BY MARKET PLAYER DURING COVID 19
8.5 CONCLUSION:
9 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE
9.1 OVERVIEW
9.2 ENDOTHERAPY DEVICES
9.2.1 SPHINCTEROTOME
9.2.2 CANNULAS
9.2.3 CATHETERS
9.2.4 BALLOONS
9.2.5 LITHOTRIPTERS
9.2.6 STENTS
9.2.7 GUIDING WIRES
9.2.8 FORCEPS
9.2.9 BASKETS
9.2.10 SNARES
9.2.11 OTHERS
9.3 ENDOSCOPE
9.4 IMAGING DEVICES
9.5 OTHERS
10 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY
10.1 OVERVIEW
10.2 SINGLE USE
10.3 STANDALONE
10.4 HANDHELD
11 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE
11.1 OVERVIEW
11.2 BILIARY SPHINCTERECTOMY
11.3 BILIARY STENTING
11.4 BILIARY DILATION
11.5 PANCREATIC DUCT STENTING
11.6 PANCREATIC DUCT DILATION
11.7 PANCREATIC SPHINCTERECTOMY
12 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 BILE DUCT
12.3 PANCREAS
12.4 GALL BLADDER
12.5 LIVER
12.6 OTHERS
13 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.3 AMBULATORY SURGICAL CENTERS
13.4 DIAGNOSTIC LABORATORIES
13.5 OTHERS
14 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE
14.1 OVERVIEW
14.2 LARGE
14.3 MEDIUM
14.4 SMALL
15 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL
15.1 OVERVIEW
15.2 DIRECT TENDERS
15.3 THIRD PARTY DISTRIBUTION
15.4 RETAIL SALES
16 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION
16.1 MIDDLE EAST AND AFRICA
16.1.1 SOUTH AFRICA
16.1.2 SAUDI ARABIA
16.1.3 U.A.E.
16.1.4 EGYPT
16.1.5 ISRAEL
16.1.6 REST OF MIDDLE EAST AND AFRICA
17 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
18 SWOT ANALYSIS
19 COMPANY PROFILE
19.1 OLYMPUS CORPORATION
19.1.1 COMPANY SNAPSHOT
19.1.2 REVENUE ANALYSIS
19.1.3 COMPANY SHARE ANALYSIS
19.1.4 PRODUCT PORTFOLIO
19.1.5 RECENT DEVELOPMENTS
19.2 BOSTON SCIENTIFIC CORPORATION
19.2.1 COMPANY SNAPSHOT
19.2.2 REVENUE ANALYSIS
19.2.3 COMPANY SHARE ANALYSIS
19.2.4 PRODUCT PORTFOLIO
19.2.5 RECENT DEVELOPMENTS
19.3 STERIS
19.3.1 COMPANY SNAPSHOT
19.3.2 REVENUE ANALYSIS
19.3.3 COMPANY SHARE ANALYSIS
19.3.4 PRODUCT PORTFOLIO
19.3.5 RECENT DEVELOPMENTS
19.4 FUJIFILM CORPORATION
19.4.1 COMPANY SNAPSHOT
19.4.2 REVENUE ANALYSIS
19.4.3 COMPANY SHARE ANALYSIS
19.4.4 PRODUCT PORTFOLIO
19.4.5 RECENT DEVELOPMENTS
19.5 BD
19.5.1 COMPANY SNAPSHOT
19.5.2 REVENUE ANALYSIS
19.5.3 COMPANY SHARE ANALYSIS
19.5.4 PRODUCT PORTFOLIO
19.5.5 RECENT DEVELOPMENTS
19.6 MEDTRONIC
19.6.1 COMPANY SNAPSHOT
19.6.2 REVENUE ANALYSIS
19.6.3 PRODUCT PORTFOLIO
19.6.4 RECENT DEVELOPMENTS
19.7 JOHNSON & JOHNSON SERVICES, INC.
19.7.1 COMPANY SNAPSHOT
19.7.2 REVENUE ANALYSIS
19.7.3 PRODUCT PORTFOLIO
19.7.4 RECENT DEVELOPMENTS
19.8 AMBU INC.
19.8.1 COMPANY SNAPSHOT
19.8.2 REVENUE ANALYSIS
19.8.3 PRODUCT PORTFOLIO
19.8.4 RECENT DEVELOPMENTS
19.9 CONMED CORPORATION
19.9.1 COMPANY SNAPSHOT
19.9.2 REVENUE ANALYSIS
19.9.3 PRODUCT PORTFOLIO
19.9.4 RECENT DEVELOPMENTS
19.1 COOK
19.10.1 COMPANY SNAPSHOT
19.10.2 PRODUCT PORTFOLIO
19.10.3 RECENT DEVELOPMENT
19.11 HOBBS MEDICAL INC.
19.11.1 COMPANY SNAPSHOT
19.11.2 PRODUCT PORTFOLIO
19.11.3 RECENT DEVELOPMENT
19.12 HOSPILINE EQUIPMENTS
19.12.1 COMPANY SNAPSHOT
19.12.2 PRODUCT PORTFOLIO
19.12.3 RECENT DEVELOPMENT
19.13 HOYA CORPORATION
19.13.1 COMPANY SNAPSHOT
19.13.2 REVENUE ANALYSIS
19.13.3 PRODUCT PORTFOLIO
19.13.4 RECENT DEVELOPMENT
19.14 KARL STORZ SE & CO. KG
19.14.1 COMPANY SNAPSHOT
19.14.2 PRODUCT PORTFOLIO
19.14.3 RECENT DEVELOPMENTS
19.15 MEDI-GLOBE GMBH
19.15.1 COMPANY SNAPSHOT
19.15.2 PRODUCT PORTFOLIO
19.15.3 RECENT DEVELOPMENT
19.16 MERIT MEDICAL SYSTEMS
19.16.1 COMPANY SNAPSHOT
19.16.2 REVENUE ANALYSIS
19.16.3 PRODUCT PORTFOLIO
19.16.4 RECENT DEVELOPMENT
19.17 SHAILI ENDOSCOPY
19.17.1 COMPANY SNAPSHOT
19.17.2 PRODUCT PORTFOLIO
19.17.3 RECENT DEVELOPMENT
19.18 TELEMED SYSTEMS, INC.
19.18.1 COMPANY SNAPSHOT
19.18.2 PRODUCT PORTFOLIO
19.18.3 RECENT DEVELOPMENT
20 QUESTIONNAIRE
21 RELATED REPORTS
표 목록
TABLE 1 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 2 MIDDLE EAST AND AFRICA ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 MIDDLE EAST AND AFRICA ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 4 MIDDLE EAST AND AFRICA ENDOSCOPE IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA IMAGING DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA OTHERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA SINGLE USE IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA STANDALONE IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA HANDHELD IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA BILIARY SPHINCTERECTOMY IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA BILIARY STENTING IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA BILIARY DILATION IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA PANCREATIC DUCT STENTING IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA PANCREATIC DUCT DILATION IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA PANCREATIC SPHINCTERECTOMY IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA BILE DUCT IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA PANCREAS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA GALL BLADDER IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA LIVER IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA OTHERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA HOSPITALS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA AMBULATORY SURGICAL CENTERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA DIAGNOSTIC LABORATORIES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA OTHERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST AND AFRICA LARGE IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA MEDIUM IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA SMALL IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA DIRECT TENDERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA THIRD PARTY DISTRIBUTION IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA RETAIL SALES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 42 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 46 SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 47 SOUTH AFRICA ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 48 SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 49 SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 50 SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 51 SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 52 SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)
TABLE 53 SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 54 SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 55 SAUDI ARABIA ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 56 SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 57 SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 58 SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 59 SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 60 SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)
TABLE 61 SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 62 U.A.E. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 63 U.A.E. ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 64 U.A.E. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 65 U.A.E. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 66 U.A.E. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 67 U.A.E. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 68 U.A.E. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)
TABLE 69 U.A.E. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 70 EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 71 EGYPT ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 72 EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 73 EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 74 EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 75 EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 76 EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)
TABLE 77 EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 78 ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 79 ISRAEL ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 80 ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 81 ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 82 ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 83 ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 84 ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)
TABLE 85 ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 86 REST OF MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
그림 목록
FIGURE 1 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET : MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: SEGMENTATION
FIGURE 11 THE HIGH PREVALENCE OF PANCREATIC AND BILIARY DISEASES IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 ENDOTHERAPY DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET
FIGURE 14 PANCREATIC CANCER MORTALITY, BY REGION (2020)
FIGURE 15 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE, 2020
FIGURE 16 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE, 2021-2028 (USD MILLION)
FIGURE 17 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE, CAGR (2021-2028)
FIGURE 18 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 19 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY MODALITY, 2020
FIGURE 20 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY MODALITY, 2021-2028 (USD MILLION)
FIGURE 21 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY MODALITY, CAGR (2021-2028)
FIGURE 22 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY MODALITY, LIFELINE CURVE
FIGURE 23 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PROCEDURE, 2020
FIGURE 24 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PROCEDURE, 2021-2028 (USD MILLION)
FIGURE 25 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PROCEDURE, CAGR (2021-2028)
FIGURE 26 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PROCEDURE, LIFELINE CURVE
FIGURE 27 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY APPLICATION, 2020
FIGURE 28 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 29 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 30 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 31 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY END USER, 2020
FIGURE 32 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY END USER, 2021-2028 (USD MILLION)
FIGURE 33 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY END USER, CAGR (2021-2028)
FIGURE 34 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY END USER, LIFELINE CURVE
FIGURE 35 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY FACILITY TYPE, 2020
FIGURE 36 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY FACILITY TYPE, 2021-2028 (USD MILLION)
FIGURE 37 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY FACILITY TYPE, CAGR (2021-2028)
FIGURE 38 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY FACILITY TYPE, LIFELINE CURVE
FIGURE 39 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 40 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 41 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 42 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 43 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: SNAPSHOT (2020)
FIGURE 44 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY COUNTRY (2020)
FIGURE 45 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 46 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 47 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE (2021-2028)
FIGURE 48 MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: COMPANY SHARE 2020 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
